The Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world.
Reihe
Auflage
Sprache
Verlagsort
Verlagsgruppe
Dateigröße
ISBN-13
978-0-470-71805-6 (9780470718056)
Schweitzer Klassifikation
Ruth Porter is the editor of Hepatotrophic Factors, published by Wiley.
Julie Whelan is the editor of Hepatotrophic Factors, published by Wiley.
1 - Hepatotrophic Factors [Seite 1]
1.1 - Contents [Seite 7]
1.1.1 - Introduction [Seite 13]
1.1.2 - Ultrastructural and metabolic studies of isolated and cultured hepatocytes [Seite 19]
1.1.2.1 - Discussion [Seite 36]
1.1.3 - Kinetics of hepatocellular proliferation as a function of the microvascular structure and functional state of the liver [Seite 43]
1.1.3.1 - Discussion [Seite 65]
1.1.4 - Proliferation of hepatocytes [Seite 73]
1.1.4.1 - Discussion [Seite 94]
1.1.5 - Hormonal factors concerned with liver regeneration [Seite 107]
1.1.5.1 - Discussion [Seite 119]
1.1.6 - A hundred years of the hepatotrophic controversy [Seite 123]
1.1.6.1 - Discussion [Seite 141]
1.1.7 - Other views about the hepatotrophic concept [Seite 151]
1.1.7.1 - Discussion [Seite 155]
1.1.8 - Signals for insulin secretion [Seite 165]
1.1.9 - Signals for glucagon secretion [Seite 173]
1.1.9.1 - Discussion [Seite 184]
1.1.10 - Liver atrophy, hypertrophy and regenerative hyperplasia in the rat: the relevance of blood flow [Seite 193]
1.1.10.1 - Discussion [Seite 217]
1.1.11 - Insulin as a cellular growth regulator [Seite 229]
1.1.12 - Insulin-induced liver hyperplasia: evidence for a negative liversize-correcting process [Seite 241]
1.1.13 - Discussion of the two preceding papers [Seite 249]
1.1.14 - Amino acid transport in isolated hepatocytes: effect of glucagon [Seite 259]
1.1.14.1 - Discussion [Seite 274]
1.1.15 - Hepatotrophic effects of pancreatic and gastrointestinal hormones in the rat in vivo and in vitro [Seite 281]
1.1.15.1 - Discussion [Seite 295]
1.1.16 - Studies on plasma cytotoxicity and liver regeneration in fulminant hepatic failure [Seite 311]
1.1.16.1 - Discussion [Seite 317]
1.1.17 - Portacaval shunt for glycogen storage disease and hyperlipidaemia [Seite 323]
1.1.17.1 - Discussion [Seite 337]
1.1.18 - Glycogen storage disease: new approaches to therapy [Seite 343]
1.1.18.1 - Discussion [Seite 364]
1.1.19 - Hepatotrophic factors: implications for diabetes mellitus [Seite 369]
1.1.19.1 - Discussion [Seite 385]
1.1.20 - General discussion [Seite 393]
1.1.21 - Index of contributors [Seite 409]
1.1.22 - Subject index [Seite 411]
